专题：Spondyloarthritis Studies and Treatments

This cluster of papers focuses on the classification, diagnosis, and treatment of spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis. It covers the development of new classification criteria, assessment of disease activity, use of biologic therapies such as tumor necrosis factor inhibitors and interleukin-17 inhibitors, and the impact of genetic factors like HLA-B27.
最新文献
Comment on: FIB-4 as an effective screening tool in psoriatic arthritis patients at high-risk for liver disease: a cross-sectional study using FibroScan

article Full Text OpenAlex

Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis (COSPIRIT-JIA): a multicentre, open-label, 16-week, Bayesian trial including a randomised reference group to adalimumab

article Full Text OpenAlex

Disease Damage in Juvenile Idiopathic Arthritis: Correspondence

article Full Text OpenAlex

Exploring the risk association between psoriasis and chronic obstructive pulmonary disease, and asthma using the NHIS database

article Full Text OpenAlex

Risk Factors for Major Adverse Cardiovascular Events, Malignancies, and Serious Infections With Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of a 3‐Year J‐Post‐Marketing Surveillance

article Full Text OpenAlex

Tenosinovitis tuberculosa en la muñeca: presentación de un caso

article Full Text OpenAlex

JAK/STAT Pathway in Psoriasis and Psoriatic Arthritis: Insights into Inflammation and Tissue Remodeling

article Full Text OpenAlex

Spontaneous remission in statin-associated HMGCR-positive immune-mediated necrotizing myopathy after statin withdrawal

article Full Text OpenAlex

Characteristics, treatments and outcomes of patients with dermatomyositis using real-world data

article Full Text OpenAlex

The Impact of Social Determinants of Health on Clinical Outcomes in a Cohort of Acute Charcot Neuro-Osteoarthropathy Patients

article Full Text OpenAlex

近5年高被引文献
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

article Full Text OpenAlex 825 FWCI131.784

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

review Full Text OpenAlex 550 FWCI90.2416

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

article Full Text OpenAlex 336 FWCI54.4809

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

review Full Text OpenAlex 276 FWCI131.8569

Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults

article Full Text OpenAlex 239 FWCI19.6406

2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases

review Full Text OpenAlex 217 FWCI35.4148

Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis

article Full Text OpenAlex 193 FWCI15.8128

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

article Full Text OpenAlex 190 FWCI55.6443

Indole-3-Acetic Acid Alters Intestinal Microbiota and Alleviates Ankylosing Spondylitis in Mice

article Full Text OpenAlex 152 FWCI24.0072

Psoriatic Arthritis: Pathogenesis and Targeted Therapies

review Full Text OpenAlex 150 FWCI38.2376